United States · FDA National Drug Code directory
buprenorphine hydrochloride and naloxone hydrochloride dihydrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58118-1188_4c5e6bea-03d2-6813-e063-6294a90aa347
- Product NDC
- 58118-1188
- Form
- TABLET
- Composition / generic term
- buprenorphine hydrochloride and naloxone hydrochloride dihydrate
- Labeler
- Clinical Solutions Wholesale, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140627
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BLISTER PACK (58118-1188-8) · 58118-1188-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →